Clinical

Dataset Information

0

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors


ABSTRACT: The main purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, immune response and preliminary anti-tumor activity of RO7515629 alone in participants with advanced or metastatic solid tumors expressing human leukocyte antigen G (HLA-G).

DISEASE(S): Adenocarcinoma,Pancreatic Adenocarcinoma,Non-small Cell Lung Cancer,Colorectal Cancer,Colorectal Neoplasms,Carcinoma, Renal Cell,Carcinoma, Non-small-cell Lung,Ovarian Neoplasms,Renal Cell Carcinoma

PROVIDER: 11560 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2024-03-04 | PXD045000 | Pride
2023-11-23 | PXD038059 | JPOST Repository
| EGAS00001005274 | EGA
2017-05-04 | PXD005935 | Pride
2021-05-21 | E-MTAB-10305 | biostudies-arrayexpress
2022-11-01 | GSE216534 | GEO
2021-04-08 | PXD020292 | Pride
2022-02-15 | PXD028985 | Pride
2024-01-02 | GSE251809 | GEO
2021-03-23 | PXD023545 | Pride